Patents by Inventor Keith Al-Hasani

Keith Al-Hasani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for producing a population of pancreatic beta-cells
    Patent number: 9708608
    Abstract: The present invention relates to an in vitro or ex vivo method for producing a population of pancreatic beta-cells, comprising the step of inhibiting the expression or the activity of Arx in a population of pancreatic alpha-cells. The present invention also relates to method for inducing the conversion of pancreatic alpha-cells in pancreatic beta-cells in a patient in need thereof.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: July 18, 2017
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientific (CNRS), Universite Nice Sophia Antipolis
    Inventors: Patrick Collombat, Keith Al-Hasani, Monica Courtney, Nouha Ben-Ohtman, Elisabet Gjernes, Ahmed Mansouri
  • METHODS FOR PRODUCING A POPULATION OF PANCREATIC BETA-CELLS
    Publication number: 20150240235
    Abstract: The present invention relates to an in vitro or ex vivo method for producing a population of pancreatic beta-cells, comprising the step of inhibiting the expression or the activity of Arx in a population of pancreatic alpha-cells. The present invention also relates to method for inducing the conversion of pancreatic alpha-cells in pancreatic beta-cells in a patient in need thereof.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 27, 2015
    Inventors: Patrick Collombat, Keith Al-Hasani, Monica Courtney, Nouha Ben-Ohtman, Elisabet Gjernes, Ahmed Mansouri
  • Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
    Publication number: 20100068214
    Abstract: This invention relates to a prophylactic and/or therapeutic treatment of footrot, and in particular to a vaccine effective in prophylactic and/or therapeutic treatment of footrot. Specific polypeptides of Dichelobacter nodosus have been identified as vaccine candidates. In some embodiments the polypeptide is expressed more strongly when the bacterium is grown in vivo or is expressed more strongly in the presence of ovine hoof powder. In other embodiments the polypeptide are reactive against sera recovered from animals repeatedly infected with D. nodosus.
    Type: Application
    Filed: December 19, 2007
    Publication date: March 18, 2010
    Applicant: Monash University
    Inventors: Julian Rood, Keith Al-Hasani, John Boyce, Dane Parker